Omacetaxine for Consolidation and Maintenance in Patients Age ≥ 55 With AML in First Remission: A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2018
At a glance
- Drugs Omacetaxine mepesuccinate (Primary) ; Anthracyclines; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2018 Status changed from recruiting to completed.
- 06 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 28 Mar 2017 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.